Skip to main content

Table 2 The clinicopathological relevance of CD56 expression in ALK+ sALCLs

From: The clinicopathological relevance of uniform CD56 expression in anaplastic large cell lymphoma: a retrospective analysis of 18 cases

  Total (%) CD56+ group (%) CD56- group (%) p value
Sex 64 13 51 0.706
 Male 47 (73.4) 9 (69.2) 38 (74.5)  
 Female 17 (26.6) 4 (30.8) 13 (25.5)  
Age 64 13 51 0.427
 Median 23 20 23  
 Range 5–74 8–60 5–74  
Stage 46 13 33 0.015*
 I-II 26 (56.5) 11 (84.6) 15 (45.5)  
 III-IV 20 (43.5) 2 (15.4) 18 (54.5)  
Site 64 13 51 0.038*
 Nodal 26 (40.6) 2 (15.4) 24 (47.1)  
 Extranodal 38 (59.4) 11 (84.6) 27 (52.9)  
B symptoms 37 12 25 0.308
 With 20 (54.1) 5 (41.7) 15 (60.0)  
 Without 17 (45.9) 7 (58.3) 10 (40.0)  
  1. * Statistically significant p values are in bold